Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengxing Group, primarily known through its flagship entity Jiangsu Chengxing Phosph-Chemical, is a major Chinese industrial conglomerate with a significant presence in the pharmaceutical supply chain. The company is a leading global producer of fine phosphorus chemicals, including pharmaceutical-grade phosphoric acid and phosphates used as excipients and reagents. Through its subsidiary, Zhejiang Chengxing Pharmaceutical, the group operates as a manufacturer of active pharmaceutical ingredients (APIs) and intermediates, producing generic drugs such as gabapentin and valproic acid. While the group has faced financial restructuring in recent years, it remains a critical supplier to the global healthcare and food industries. Its operations span chemical production, logistics, and specialized pharmaceutical manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengxing Group.